Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gérardin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|May 3, 1997
[Mucoviscidosis. Nutritional management]A Munck, M Gérardin, J Navarro
Presse Medicale (Paris, France : 1983)|May 3, 1997
[Mucoviscidosis. Antibiotic management]M Le Bourgeois, M Gérardin, A Munck, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 25, 2017
[Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis]D Debray, E Mas, A Munck, et al.
Data in Brief|December 13, 2021
Experimental measurements of Xe and Kr releases from UO<sub>2</sub> and determination of their migration mechanisms - Release rate dataM Gérardin, E Gilabert, D Horlait, et al.
Addictive Behaviors|December 10, 2013
Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reportsL Gaboriau, C Victorri-Vigneau, M Gérardin, et al.
Pediatric Pulmonology|September 25, 2001
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonizationA Munck, S Bonacorsi, P Mariani-Kurkdjian, et al.
The British Journal of Dermatology|October 30, 2014
Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French surveyL Wainstein, C Bernier, M Gérardin, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosisE Jacquemin, B Hermeziu, Y Kibleur, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|May 3, 1997
[Mucoviscidosis. Nutritional management]A Munck, M Gérardin, J Navarro
Presse Medicale (Paris, France : 1983)|May 3, 1997
[Mucoviscidosis. Antibiotic management]M Le Bourgeois, M Gérardin, A Munck, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 25, 2017
[Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis]D Debray, E Mas, A Munck, et al.
Data in Brief|December 13, 2021
Experimental measurements of Xe and Kr releases from UO<sub>2</sub> and determination of their migration mechanisms - Release rate dataM Gérardin, E Gilabert, D Horlait, et al.
Addictive Behaviors|December 10, 2013
Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reportsL Gaboriau, C Victorri-Vigneau, M Gérardin, et al.
Pediatric Pulmonology|September 25, 2001
Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonizationA Munck, S Bonacorsi, P Mariani-Kurkdjian, et al.
The British Journal of Dermatology|October 30, 2014
Livedo-like dermatitis and necrotic lesions after high-dose buprenorphine injections: a national French surveyL Wainstein, C Bernier, M Gérardin, et al.
Journal of Clinical Pharmacy and Therapeutics|September 12, 2009
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosisE Jacquemin, B Hermeziu, Y Kibleur, et al.
Pageof 1